SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-19-028713
Filing Date
2019-05-29
Accepted
2019-05-29 21:56:14
Documents
2
Period of Report
2019-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 tv522240_3.html 3  
1 FORM 3 tv522240_3.xml 3 1576
2 EXHIBIT 24.1 tv522240_ex24-1.htm EX-24.1 11161
  Complete submission text file 0001144204-19-028713.txt   14326
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHIBRO, GLENPOINTE CENTRE EAST 3RD FL, 300 FRANK W. BURR BLVD, STE 21 TEANECK NJ 07666
Business Address
Aukerman Robin (Reporting) CIK: 0001777706 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36410 | Film No.: 19864276